From the Research
FemiLift (CO2 laser) is generally the preferred treatment option for vaginal rejuvenation and improvement of sexual function, especially for women concerned with vaginal laxity, dryness, and sexual discomfort, as it directly stimulates collagen production in vaginal tissues through controlled thermal injury, as supported by the most recent and highest quality study 1. The choice between FemiLift and Emsella (electromagnetic chair) depends on specific symptoms.
- For women primarily concerned with vaginal laxity, dryness, and sexual discomfort, FemiLift is more effective as it directly stimulates collagen production in vaginal tissues through controlled thermal injury.
- For women whose primary concern is urinary incontinence with secondary sexual function benefits, Emsella may be preferable as it strengthens pelvic floor muscles through electromagnetic stimulation. The procedure typically requires 3 sessions spaced 4-6 weeks apart, with each session lasting about 30 minutes, and results can last 12-18 months before maintenance treatments are needed, as shown in a study comparing vaginal laser therapy to vaginal estrogen therapy 2. Some women achieve optimal results by combining both therapies - using FemiLift to address tissue quality and Emsella for muscle strength, and both procedures are non-surgical with minimal downtime, though FemiLift may require 2-3 days of abstaining from sexual intercourse after treatment, as reported in a study on fractional CO2 laser for vulvo-vaginal reshaping 3. The choice should be guided by predominant symptoms and a consultation with a specialist who can assess individual needs, considering the benefits and limitations of each treatment option, as discussed in a review of new innovations for the treatment of vulvovaginal atrophy 1.